Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

P53 Pathway Activation Mediated High c-MAF Expression Is Associated with Overall and Post-Progression Survival in Multiple Myeloma

Blood (2019) 134 (Supplement_1): 4330.

https://doi.org/10.1182/blood-2019-125172

Published: 2019

Journal Articles

DNA Polymerases Pol θ/Pol η Involved in Error-Prone DNA Repair Are Highly Expressed in Multiple Myeloma and Upregulated By DNA Damage

Blood (2019) 134 (Supplement_1): 4364.

https://doi.org/10.1182/blood-2019-125163

Published: 2019

Journal Articles

Impact of Continuous and Maintenance Therapy on Survival Outcome in Patients with Newly Diagnosed Multiple Myeloma: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

Shuji Ozaki, MD PhD, Hiroshi Handa, MD PhD, Takayuki Saitoh, MD PhD, Kazutaka Sunami, MD PhD, Tadao Ishida, MD PhD, Kenshi Suzuki, MD PhD, Tomoko Narita, MD, Shinsuke Iida, MD PhD, Yuichi Nakamura, MD PhD, Kazuhito Suzuki, MD, Noriko Nishimura, MD PhD, Hirokazu Murakami, MD PhD, Kazuyuki Shimizu, MD

Blood (2019) 134 (Supplement_1): 3085.

https://doi.org/10.1182/blood-2019-125390

Published: 2019

Journal Articles

Th1 Cytokine Polymorphism Gene: TNF-Alpha -857C/T Affects the Pathogenesis and Progression of Acute Myeloid Leukemia

Kana Soma, Gotoh Nanami, Tetsuhiro Kasamatsu, PhD, Yuki Murakami, Master, Graduate Student, Rei Ishihara, Master, Graduate Student, Maaya Awata, Eiko Yamane, Master, Graduate Student, Masanobu Sunaga, Master, Graduate Student, Yuta Asao, Graduate Student, Nao Hashimoto, Master, Graduate Student, Yoshiyuki Ogawa, MD PhD, Hiroaki Shimizu, MD PhD, Takuma Ishizaki, MD PhD, Akihiko Yokohama, MD PhD, Norifumi Tsukamoto, MD PhD, Hiroshi Handa, MD PhD, Toru Sakura, PhD MD, Satoru Takada, MD, Takayuki Saitoh, MD PhD

Blood (2019) 134 (Supplement_1): 1431.

https://doi.org/10.1182/blood-2019-129409

Published: 2019

Journal Articles

Extramedullary Relapses after Allogeneic Stem Cell Transplant (allo-SCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Hiroaki Shimizu, MD PhD, Takuma Ishizaki, MD PhD, Nahoko Hatsumi, MD, Satoru Takada, MD, Akihiko Yokohama, MD PhD, Takayuki Saitoh, MD PhD, Toru Sakura, PhD MD, Hiroshi Handa, MD PhD

Blood (2019) 134 (Supplement_1): 5690.

https://doi.org/10.1182/blood-2019-130590

Published: 2019

Journal Articles

Clinical Significance of Clonal Cytogenetic Heterogeneity (CCH) at Diagnosis in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Hiroaki Shimizu, MD PhD, Nahoko Hatsumi, MD, Satoru Takada, MD, Takuma Ishizaki, MD PhD, Akihiko Yokohama, MD PhD, Takayuki Saitoh, MD PhD, Toru Sakura, PhD MD, Hiroshi Handa, MD PhD

Blood (2018) 132 (Supplement 1): 2820.

https://doi.org/10.1182/blood-2018-99-118462

Published: 2018

Journal Articles

Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinases Is Associated with Multiple Myeloma Progression, Prognosis and Extramedullary Plasmacytoma

Blood (2018) 132 (Supplement 1): 3178.

https://doi.org/10.1182/blood-2018-99-113355

Published: 2018

Journal Articles

Long Non-Coding RNA NEAT1 Is Upregulated By Heat Shock Factor 1 (HSF1) and Associated with Multiple Myeloma Progression

Blood (2018) 132 (Supplement 1): 1904.

https://doi.org/10.1182/blood-2018-99-113720

Published: 2018

Journal Articles

Risk Factors and Clinical Impact of Chronic Kidney Disease (CKD) after Allogeneic Stem Cell Transplant (allo-SCT)

Hiroaki Shimizu, Takuma Ishizaki, Nahoko Hatsumi, Satoru Takada, MD, Akihiko Yokohama, MD PhD, Takayuki Saitoh, MD PhD, Yoshihisa Nojima, Hiroshi Handa, MD PhD

Blood (2016) 128 (22): 3440.

https://doi.org/10.1182/blood.V128.22.3440.3440

Published: 2016

Journal Articles

Th2 Cytokine Polymorphisms, IL-4 -590 CC Genotype and IL-10RB K47E, Increase the Requirement of Second-Line Treatment for Chronic ITP

Yuya Kitamura, Takayuki Saitoh, MD PhD, Rumi Ino, Kazuki Honma, Tomomi Nagashima, Noriyuki Takahashi, Nanami Gotoh, Tetsuhiro Kasamatsu, Takuma Ishizaki, Makiko Takizawa, PhD MD, Akihiko Yokohama, MD PhD, Hiroaki Shimizu, MD PhD, Hiroshi Handa, MD PhD, Norifumi Tsukamoto, MD PhD, Hirokazu Murakami, MD PhD

Blood (2016) 128 (22): 3739.

https://doi.org/10.1182/blood.V128.22.3739.3739

Published: 2016

Journal Articles

One-Time Administration of Recombinant Human Erythropoietin Decreases B Cell in Human Peripheral Blood

Tomomi Nagashima, Akihiko Yokohama, MD PhD, Kie Nagai, Rumi Ino, Noriyuki Takahashi, Tetsuhiro Kasamatsu, Tomomi Sekigami, Hirono Iriuchishima, MD PhD, Makiko Takizawa, PhDMD, Hiroshi Handa, MD PhD, Takayuki Saitoh, MD PhD, Hirokazu Murakami, MD PhD

Blood (2016) 128 (22): 4899.

https://doi.org/10.1182/blood.V128.22.4899.4899

Published: 2016

Journal Articles

A New Prognostic Scoring System for Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

Shuji Ozaki, MD PhD, Takayuki Saitoh, MD PhD, Hiroshi Handa, MD PhD, Kenshi Suzuki, MD PhD, Naoki Takezako, MD PhD, Kazutaka Sunami, MD, Yoshiaki Kuroda, MD, Mitsuhiro Itagaki, MD, Hideki Asaoku, MD, Eiichi Nagura, MD, Shimizu Kazuyuki, MD, Hirokazu Murakami, MD PhD

Blood (2016) 128 (22): 4436.

https://doi.org/10.1182/blood.V128.22.4436.4436

Published: 2016

Journal Articles

Base Excision Repair Gene OGG1 Affects the Relapse Risk of Acute Myeloid Leukemia

Nanami Gotoh, Takayuki Saitoh, MD PhD, Noriyuki Takahashi, Rumi Ino, Yuya Kitamura, Kazuki Honma, Tomomi Nagashima, Tetsuhiro Kasamatsu, Takumi Hoshino, MD, Toru Sakura, MD, Makiko Takizawa, Ph DMD, Akihiko Yokohama, MD PhD, Hiroaki Shimizu, MD PhD, Hiroshi Handa, MD PhD, Norifumi Tsukamoto, MD PhD, Hirokazu Murakami, MD PhD

Blood (2016) 128 (22): 2901.

https://doi.org/10.1182/blood.V128.22.2901.2901

Published: 2016

Journal Articles

Prognostic Impact of Cytogenetic Abnormalities in Adult Patients with Philadelphia-Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) Who Underwent Allogeneic Stem Cell Transplant (allo-SCT)

Blood (2015) 126 (23): 2024.

https://doi.org/10.1182/blood.V126.23.2024.2024

Published: 2015

Journal Articles

A Revised International Staging System of Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation in Japan: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

Shuji Ozaki, MD PhD, Takayuki Saitoh, MD PhD, Hiroshi Handa, MD PhD, Hirokazu Murakami, MD, Kenshi Suzuki, Naoki Takezako, MD PhD, Jun Konishi, Kazutaka Sunami, Yoshiaki Kuroda, Mitsuhiro Itagaki, MD, Hideki Asaoku, MD, Eiichi Nagura, MD, Kazuyuki Shimizu, MD

Blood (2015) 126 (23): 4199.

https://doi.org/10.1182/blood.V126.23.4199.4199

Published: 2015

Journal Articles

Methylation and Hydroxymethylation Status of Tumor Suppressor Genes and Common Fragile Sites Genes in Acute Myeloid Leukemia

Blood (2014) 124 (21): 3535.

https://doi.org/10.1182/blood.V124.21.3535.3535

Published: 2014

Journal Articles

Clinical Significance of Additional Cytogenetic Abnormalities (ACA) Acquired at the First Relapse in Adult Acute Myeloid Leukemia (AML) Patients

Hiroaki Shimizu, MDPhD, Akihiko Yokohama, MD PhD, Nahoko Hatsumi, MD, Satoru Takada, MD, Takayuki Saitoh, MD, PhD, Hiroshi Handa, MD, Toru Sakura, MD PhD, Yoshihisa Nojima, MD PhD

Blood (2014) 124 (21): 3673.

https://doi.org/10.1182/blood.V124.21.3673.3673

Published: 2014

Journal Articles

Survival of Multiple Myeloma Patients in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

Shuji Ozaki, Hiroshi Handa, MD PhD, Takayuki Saitoh, MD, PhD, Hirokazu Murakami, MD, PhD, Mitsuhiro Itagaki, MD, Hideki Asaoku, MD, Kenshi Suzuki, MD PhD, Atsushi Isoda, MD PhD, Morio Sawamura, MD PhD, Jun Konishi, MD, Kazutaka Sunami, Naoki Takezako, MD PhD, Shotaro Hagiwara, MD PhD, Yoshiaki Kuroda, MD PhD, Takaaki Chou, Eiko Shibata, Kazuyuki Shimizu, MD, Eiichi Nagura, MD

Blood (2014) 124 (21): 5684.

https://doi.org/10.1182/blood.V124.21.5684.5684

Published: 2014

Journal Articles

Primary Plasma Cell Leukemia in the Era of Novel Agent: Report of Multicenter Study from Japanese Society of Myeloma.

Hirono Iriuchishima, MD PhD, Hirokazu Murakami, MDPhD, Shuji Ozaki, Hiroshi Handa, MD PhD, Takayuki Saitoh, MD, PhD, Eiichi Nagura, MD, Kazuyuki Shimizu, MD

Blood (2014) 124 (21): 2008.

https://doi.org/10.1182/blood.V124.21.2008.2008

Published: 2014

Journal Articles

BCL6 Dose Not Negatively Regulate DNA Damage Response Genes in Multiple Myeloma Cells

Kenichi Tahara, MD, Makiko Takizawa, MD, PhD, Hiroshi Handa, MD, PhD, Yuta Masuda, Ayaka Kaneko, Itsumi Suda, Kei Kimura, Yuko Kuroda, Isoda Atsushi, MD, PhD, Morio Matsumoto, Hiromi Koiso, MD, PhD, Ishizaki Takuma, MD, PhD, Takeki Mitsui, MD, PhD, Akihiko Yokohama, MD, PhD, Takayuki Saitoh, MD, PhD, Norifumi Tsukamoto, MD, PhD, Hirokazu Murakami, MD, PhD

Blood (2014) 124 (21): 2035.

https://doi.org/10.1182/blood.V124.21.2035.2035

Published: 2014

NARROW

P53 Pathway Activation Mediated High c-MAF Expression Is Associated with Overall and Post-Progression Survival in Multiple Myeloma

DNA Polymerases Pol θ/Pol η Involved in Error-Prone DNA Repair Are Highly Expressed in Multiple Myeloma and Upregulated By DNA Damage

Impact of Continuous and Maintenance Therapy on Survival Outcome in Patients with Newly Diagnosed Multiple Myeloma: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

Th1 Cytokine Polymorphism Gene: TNF-Alpha -857C/T Affects the Pathogenesis and Progression of Acute Myeloid Leukemia

Extramedullary Relapses after Allogeneic Stem Cell Transplant (allo-SCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Clinical Significance of Clonal Cytogenetic Heterogeneity (CCH) at Diagnosis in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinases Is Associated with Multiple Myeloma Progression, Prognosis and Extramedullary Plasmacytoma

Long Non-Coding RNA NEAT1 Is Upregulated By Heat Shock Factor 1 (HSF1) and Associated with Multiple Myeloma Progression

Risk Factors and Clinical Impact of Chronic Kidney Disease (CKD) after Allogeneic Stem Cell Transplant (allo-SCT)

Th2 Cytokine Polymorphisms, IL-4 -590 CC Genotype and IL-10RB K47E, Increase the Requirement of Second-Line Treatment for Chronic ITP

One-Time Administration of Recombinant Human Erythropoietin Decreases B Cell in Human Peripheral Blood

A New Prognostic Scoring System for Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

Base Excision Repair Gene OGG1 Affects the Relapse Risk of Acute Myeloid Leukemia

Prognostic Impact of Cytogenetic Abnormalities in Adult Patients with Philadelphia-Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) Who Underwent Allogeneic Stem Cell Transplant (allo-SCT)

A Revised International Staging System of Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation in Japan: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

Methylation and Hydroxymethylation Status of Tumor Suppressor Genes and Common Fragile Sites Genes in Acute Myeloid Leukemia

Clinical Significance of Additional Cytogenetic Abnormalities (ACA) Acquired at the First Relapse in Adult Acute Myeloid Leukemia (AML) Patients

Survival of Multiple Myeloma Patients in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

Primary Plasma Cell Leukemia in the Era of Novel Agent: Report of Multicenter Study from Japanese Society of Myeloma.

BCL6 Dose Not Negatively Regulate DNA Damage Response Genes in Multiple Myeloma Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only